AU1836900A - N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase - Google Patents
N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinaseInfo
- Publication number
- AU1836900A AU1836900A AU18369/00A AU1836900A AU1836900A AU 1836900 A AU1836900 A AU 1836900A AU 18369/00 A AU18369/00 A AU 18369/00A AU 1836900 A AU1836900 A AU 1836900A AU 1836900 A AU1836900 A AU 1836900A
- Authority
- AU
- Australia
- Prior art keywords
- inhibitors
- matrix metalloproteinase
- carboxymethyl substituted
- benzolactams
- substituted benzolactams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22454998A | 1998-12-31 | 1998-12-31 | |
| US09224549 | 1998-12-31 | ||
| PCT/US1999/028339 WO2000040564A1 (en) | 1998-12-31 | 1999-11-30 | N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1836900A true AU1836900A (en) | 2000-07-24 |
Family
ID=22841168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU18369/00A Abandoned AU1836900A (en) | 1998-12-31 | 1999-11-30 | N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1150957A1 (en) |
| AR (1) | AR023366A1 (en) |
| AU (1) | AU1836900A (en) |
| CA (1) | CA2358955A1 (en) |
| WO (1) | WO2000040564A1 (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3738434T (en) | 2011-12-28 | 2023-11-13 | Global Blood Therapeutics Inc | Intermediates to obtain substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation |
| ES2790358T3 (en) | 2011-12-28 | 2020-10-27 | Global Blood Therapeutics Inc | Substituted Heteroaryl Aldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation |
| US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| PE20160078A1 (en) | 2013-03-15 | 2016-03-02 | Global Blood Therapeutics Inc | COMPOUNDS AND THEIR USES TO MODULATE HEMOGLOBIN |
| US10100043B2 (en) | 2013-03-15 | 2018-10-16 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
| CN105073728A (en) | 2013-03-15 | 2015-11-18 | 全球血液疗法股份有限公司 | Compounds and uses thereof for the modulation of hemoglobin |
| US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
| US20140274961A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| EA033555B1 (en) | 2013-03-15 | 2019-10-31 | Global Blood Therapeutics Inc | Pharmaceutical compositions for treating sickle cell disorder |
| EA201992707A1 (en) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | COMPOUNDS AND THEIR APPLICATIONS FOR HEMOGLOBIN MODULATION |
| MY189995A (en) | 2014-02-07 | 2022-03-22 | Global Blood Therapeutics Inc | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
| MA41841A (en) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | ALDEHYDE COMPOUNDS FOR THE TREATMENT OF PULMONARY FIBROSIS, HYPOXIA, AND AUTOIMMUNE AND CONNECTIVE TISSUE DISEASES |
| US11020382B2 (en) | 2015-12-04 | 2021-06-01 | Global Blood Therapeutics, Inc. | Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
| AR108435A1 (en) | 2016-05-12 | 2018-08-22 | Global Blood Therapeutics Inc | PROCESS TO SYNTHETIZE 2-HYDROXI-6 - ((2- (1-ISOPROPIL-1H-PIRAZOL-5-IL) -PIRIDIN-3-IL) METOXI) BENZALDEHYDE |
| TWI778983B (en) | 2016-10-12 | 2022-10-01 | 美商全球血液治療公司 | Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
| ES2966707T3 (en) | 2018-10-01 | 2024-04-23 | Global Blood Therapeutics Inc | Hemoglobin modulators for the treatment of sickle cell disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5491143A (en) * | 1990-10-18 | 1996-02-13 | Merrell Dow Pharmaceuticals Inc. | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE |
| KR100276029B1 (en) * | 1992-02-14 | 2000-12-15 | 슈테펜엘.네스비트 | Aminoacetylmercaptoacetylamide derivatives and preparation method thereof |
| RU2124503C1 (en) * | 1992-05-18 | 1999-01-10 | И.Р.Сквибб энд Санз, Инк. | Heterocyclic nitrogen-containing derivatives of carboxylic acid, method of their synthesis, pharmaceutical composition |
| US5750521A (en) * | 1994-02-14 | 1998-05-12 | Hoechst Marion Roussel Inc. | Mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE |
| PT750631E (en) * | 1994-02-14 | 2000-07-31 | Merrell Pharma Inc | NEW MERCAPTO-AACETILAMIDE-1,3,4,5-TETRAHYDRO-BENZO) AZEPIN-3-ONA UTEIS DISSULFURET DERIVATIVES AS ENCEPHALINASE AND ACE INHIBITORS |
| US5672598A (en) * | 1995-03-21 | 1997-09-30 | The Procter & Gamble Company | Lactam-containing hydroxamic acids |
-
1999
- 1999-11-30 WO PCT/US1999/028339 patent/WO2000040564A1/en not_active Application Discontinuation
- 1999-11-30 CA CA002358955A patent/CA2358955A1/en not_active Abandoned
- 1999-11-30 AU AU18369/00A patent/AU1836900A/en not_active Abandoned
- 1999-11-30 EP EP99961877A patent/EP1150957A1/en not_active Withdrawn
- 1999-12-30 AR ARP990106863A patent/AR023366A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2358955A1 (en) | 2000-07-13 |
| AR023366A1 (en) | 2002-09-04 |
| EP1150957A1 (en) | 2001-11-07 |
| WO2000040564A1 (en) | 2000-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1836900A (en) | N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase | |
| AU2002228302A1 (en) | Matrix metalloproteinase inhibitors | |
| BR9509802A (en) | Matrix metalloprotease inhibitors | |
| AU4201799A (en) | Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors | |
| AU8858398A (en) | Matrix metalloproteinase inhibitors | |
| AU3342297A (en) | Matrix metalloproteinase inhibitors | |
| HK1045501A1 (en) | Hydroxamic acid derivatives as matrix metalloprotease inhibitors | |
| AU3929600A (en) | Matrix metalloproteinase inhibitors and method of using same | |
| AU6764400A (en) | Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors | |
| IL129035A0 (en) | 3-Mercaptoacetylamino-1,5-substituted-2-oxo- azepan derivatives useful as inhibitors of matrix metalloproteinase | |
| HUP9904664A3 (en) | Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors | |
| AU2001265182A1 (en) | Inhibitors of matrix metalloproteinases | |
| IL136889A0 (en) | Matrix metalloprotease inhibitors | |
| HRP970247A2 (en) | Substituted 4-arylbutric acid derivatives as matrix metalloprotease inhibitors | |
| AU8005100A (en) | Inhibitors of neuraminidases | |
| AU4571099A (en) | Matrix metalloproteinase proenzyme activator | |
| AU7066398A (en) | Novel use of matrix metalloproteinase inhibitors | |
| AU9747098A (en) | Aporphinoid matrix metalloproteinase inhibitors | |
| HRP970246A2 (en) | Substituted oxobutric acids as matrix metalloprotease inhibitors | |
| AU2001271068A1 (en) | Matrix metalloprotease inhibitors | |
| AU1836800A (en) | Amidomalonamides and their use as inhibitors of matrix metalloproteinase | |
| AU1926700A (en) | 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase | |
| AUPP751198A0 (en) | Purification of A1-proteinase inhibitor | |
| AU6843598A (en) | Metalloproteinase inhibitors | |
| SI1001930T1 (en) | N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |